Modern OCT devices can look inside the eye without a scalpel - but they do not always capture everything that matters. Some ...

Insilico Medicine ("Insilico," HKEX: 3696), a clinical-stage biotechnology company powered by generative AI, today announced the initiation of the Phase III clinical trial for Rentosertib, its ...

Modern OCT devices can look inside the eye without a scalpel - but they do not always capture everything that matters. Some critical information is ...

Globally recognized leader in early-phase oncology clinical development and experimental therapeutics. Strengthens strategic ...

Over the past few decades, engineers have developed various devices that can create holograms, three-dimensional (3D) or ...

A Versant Ventures-founded biotech using targeted gene modulation to build a foundational portfolio in rare monogenic ...

Anthropic’s new Claude research reveals a hidden internal “global workspace” that resembles human conscious processing, ...

You'll come for the hands-on tweaking and wealth of features, and quickly forgive some of the workflow issues when you hear ...

Radiation therapy remains a central modality in cancer treatment, but normal-tissue toxicity and long-term stochastic effects ...

Bupropion conferred modest reductions in cancer-related fatigue compared with placebo, according to results of a randomized ...

Globally recognized leader in early-phase oncology clinical development and experimental therapeutics Strengthens strategic ...

Because Krea relinquishes centralized control over the downstream deployment of its open weights, the contract legally binds ...